Considerations related to the use of recombinant human growth hormone in children

Pediatrics

Volumn 99, Issue 1, 1997, Pages 122-129

  Berlin C M , Jr ^a   McCarver May, D G ^a   Notterman, D A ^a   Ward, R M ^a   Weismann, D N ^a   Wilson, G S ^a   Wilson, J T ^a   Weller, E B ^a   Bennett, D R ^a   Mulinare, J ^a   Hoskins, I A ^a   Kaufman, P ^a   Krough, C ^a   Rieder, M J ^a   Troendler, G ^a   Yaffe, S J ^a   Cote, C J ^a   Szefler, S J ^a   Blumer, J L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

CHILD GROWTH; CLINICAL PROTOCOL; DRUG INDICATION; GROWTH HORMONE DEFICIENCY; HORMONE SYNTHESIS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MEDICAL ETHICS; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SHORT STATURE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

BODY HEIGHT; ETHICS, MEDICAL; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; RISK FACTORS;

EID: 0031004187     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.1.122     Document Type: Review

References (72)